Evidence map›Paper›PMID 38946853›Full record

ArticleWorld journal of gastrointestinal endoscopy2024

Long-term impact of artificial intelligence on colorectal adenoma detection in high-risk colonoscopy.

Kenneth W Chow, Matthew T Bell, Nicholas Cumpian, Maryanne Amour, Ryan H Hsu, Viktor E Eysselein, Neetika Srivastava, Michael W Fleischman, Sofiya Reicher

Abstract read
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kenneth W ChowDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, United States. kwchow555@gmail.com.
Matthew T BellDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Nicholas CumpianDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Maryanne AmourDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Ryan H HsuDepartment of Bioengineering, Jacobs School of Engineering, University of California, San Diego, La Jolla, CA 92093, United States.
Viktor E EysseleinDepartment of Gastroenterology, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Neetika SrivastavaDepartment of Gastroenterology, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Michael W FleischmanDepartment of Gastroenterology, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
Sofiya ReicherDepartment of Gastroenterology, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproved adenoma detection rate (ADR) has been demonstrated with artificial intelligence (AI)-assisted colonoscopy. However, data on the real-world application of AI and its effect on colorectal cancer (CRC) screening outcomes is limited.

aimTo analyze the long-term impact of AI on a diverse at-risk patient population undergoing diagnostic colonoscopy for positive CRC screening tests or symptoms.

methodsAI software (GI Genius, Medtronic) was implemented into the standard procedure protocol in November 2022. Data was collected on patient demographics, procedure indication, polyp size, location, and pathology. CRC screening outcomes were evaluated before and at different intervals after AI introduction with one year of follow-up.

resultsWe evaluated 1008 colonoscopies (278 pre-AI, 255 early post-AI, 285 established post-AI, and 190 late post-AI). The ADR was 38.1% pre-AI, 42.0% early post-AI (

conclusionIn patients with an increased pre-test probability of having an abnormal colonoscopy, the current generation of AI did not yield enhanced CRC screening metrics over high-quality colonoscopy. Although the potential of AI in colonoscopy is undisputed, current AI technology may not universally elevate screening metrics across all situations and patient populations. Future studies that analyze different AI systems across various patient populations are needed to determine the most effective role of AI in optimizing CRC screening in clinical practice.

Indexed as

Adenoma detection rateArtificial intelligenceColonoscopyColorectal adenomaScreening

Identifiers

PMID38946853
PMCPMC11212514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.